Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 20)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
9-Feb-10 New Constructs, LLC N/A ORXE: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Consulting Industry Market Research and Competitive Analysis 2009 408 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Consulting Industry Trends, Statistics & Analysis 2009 (Summary) 29 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
8-Feb-10 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for ORXE 13 $25 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: IDIX , ITMN , ISIS , MYGN , ORXE , OSIP -- DRUGS 3 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: ORE PHARM HLD -- ORXE 1 $4 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ORXE: the economy's impact on ORXE's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ORE PHARMACEUTICAL HOLDINGS 5 $25 View Abstract
Next 10

Independent Reports (Showing 1 to 10 of 20)

Release
Date Contributor Author Title Pages Price More Info
9-Feb-10 New Constructs, LLC N/A ORXE: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Consulting Industry Market Research and Competitive Analysis 2009 408 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Consulting Industry Trends, Statistics & Analysis 2009 (Summary) 29 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
8-Feb-10 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for ORXE 13 $25 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: IDIX , ITMN , ISIS , MYGN , ORXE , OSIP -- DRUGS 3 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: ORE PHARM HLD -- ORXE 1 $4 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ORXE: the economy's impact on ORXE's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ORE PHARMACEUTICAL HOLDINGS 5 $25 View Abstract
Next 10

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.